| Dr Andres Krauthamer, MD | |
|
4300 Alton Rd Ste 2071, Miami Beach, FL 33140-2948 | |
| (305) 674-2071 | |
| (305) 535-7983 |
| Full Name | Dr Andres Krauthamer |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 15 Years |
| Location | 4300 Alton Rd Ste 2071, Miami Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417274481 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Sinai Medical Center | Miami beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mount Sinai Vascular Institute, Llc | 2567866296 | 9 |
News Archive
Cannabis Science, Inc., a pioneering pharmaceutical cannabis company, is pleased to announce that it has formalized its agreement with a privately owned, highly specialized international FDA regulatory compliance firm. The compliance firm will review and prepare technical data for Cannabis Science's FDA Pre-Investigative New Drug submission package for its Veterans PTSD Project.
A checklist for use by ambulance crews helps paramedics decide which drunk patients need emergency medical care and which can be diverted to a detoxification facility, say researchers.
A measles outbreak in a vaccination-wary North Texas megachurch and soaring rates of whooping cough across the state are drawing renewed calls for immunization legislation, which some lawmakers and medical professionals argue would help the state prevent public health crises (Aaronson, 9/10).
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced updates on its lead product candidates, XmAb®5871 and XmAb®7195, and on its XmAb® bispecific oncology pipeline.
› Verified 5 days ago
| Entity Name | University Of Miami |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013967827 PECOS PAC ID: 3274795109 Enrollment ID: O20200406001006 |
News Archive
Cannabis Science, Inc., a pioneering pharmaceutical cannabis company, is pleased to announce that it has formalized its agreement with a privately owned, highly specialized international FDA regulatory compliance firm. The compliance firm will review and prepare technical data for Cannabis Science's FDA Pre-Investigative New Drug submission package for its Veterans PTSD Project.
A checklist for use by ambulance crews helps paramedics decide which drunk patients need emergency medical care and which can be diverted to a detoxification facility, say researchers.
A measles outbreak in a vaccination-wary North Texas megachurch and soaring rates of whooping cough across the state are drawing renewed calls for immunization legislation, which some lawmakers and medical professionals argue would help the state prevent public health crises (Aaronson, 9/10).
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced updates on its lead product candidates, XmAb®5871 and XmAb®7195, and on its XmAb® bispecific oncology pipeline.
› Verified 5 days ago
| Entity Name | Mount Sinai Vascular Institute, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871160879 PECOS PAC ID: 2567866296 Enrollment ID: O20210803001926 |
News Archive
Cannabis Science, Inc., a pioneering pharmaceutical cannabis company, is pleased to announce that it has formalized its agreement with a privately owned, highly specialized international FDA regulatory compliance firm. The compliance firm will review and prepare technical data for Cannabis Science's FDA Pre-Investigative New Drug submission package for its Veterans PTSD Project.
A checklist for use by ambulance crews helps paramedics decide which drunk patients need emergency medical care and which can be diverted to a detoxification facility, say researchers.
A measles outbreak in a vaccination-wary North Texas megachurch and soaring rates of whooping cough across the state are drawing renewed calls for immunization legislation, which some lawmakers and medical professionals argue would help the state prevent public health crises (Aaronson, 9/10).
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced updates on its lead product candidates, XmAb®5871 and XmAb®7195, and on its XmAb® bispecific oncology pipeline.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andres Krauthamer, MD 4306 Alton Rd, Miami Beach, FL 33140-2840 Ph: (305) 535-3349 | Dr Andres Krauthamer, MD 4300 Alton Rd Ste 2071, Miami Beach, FL 33140-2948 Ph: (305) 674-2071 |
News Archive
Cannabis Science, Inc., a pioneering pharmaceutical cannabis company, is pleased to announce that it has formalized its agreement with a privately owned, highly specialized international FDA regulatory compliance firm. The compliance firm will review and prepare technical data for Cannabis Science's FDA Pre-Investigative New Drug submission package for its Veterans PTSD Project.
A checklist for use by ambulance crews helps paramedics decide which drunk patients need emergency medical care and which can be diverted to a detoxification facility, say researchers.
A measles outbreak in a vaccination-wary North Texas megachurch and soaring rates of whooping cough across the state are drawing renewed calls for immunization legislation, which some lawmakers and medical professionals argue would help the state prevent public health crises (Aaronson, 9/10).
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced updates on its lead product candidates, XmAb®5871 and XmAb®7195, and on its XmAb® bispecific oncology pipeline.
› Verified 5 days ago
Dr. Nicolas Keith Kuritzky, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4300 Alton Rd, Miami Beach, FL 33140 Phone: 305-535-3400 | |
Dr. Adam Richard Zybulewski, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4300 Alton Rd Bldg 2nd, Miami Beach, FL 33140 Phone: 305-674-3905 | |
Dr. Katrina Rabinovich, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4300 Alton Rd, Miami Beach, FL 33140 Phone: 305-535-3363 | |
Dr. Linda Hope Ripstein, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4300 Alton Rd, Radiology Dept, Miami Beach, FL 33140 Phone: 305-674-2680 | |
Dr. Viky Suncion Loescher, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4300 Alton Rd, Miami Beach, FL 33140 Phone: 305-535-7901 Fax: 305-674-2787 | |
Dr. Michael A Rogoff, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 400 W 41st St Ste 310, Miami Beach, FL 33140 Phone: 305-763-8734 Fax: 786-522-1972 | |
Dr. Michael Khalili, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1504 Bay Rd, Apartment 704, Miami Beach, FL 33139 Phone: 305-401-4157 |